Abd Eman, Namjoshi Sarika, Mohammed Yousuf H, Roberts Michael S, Grice Jeffrey E
J Pharm Sci. 2016 Jan;105(1):212-20. doi: 10.1002/jps.24699. Epub 2016 Jan 13.
We examined the extent of skin permeation enhancement of the hydrophilic drug caffeine and lipophilic drug naproxen applied in nanoemulsions incorporating skin penetration enhancers. Infinite doses of fully characterized oil-in-water nanoemulsions containing the skin penetration enhancers oleic acid or eucalyptol as oil phases and caffeine (3%) or naproxen (2%) were applied to human epidermal membranes in Franz diffusion cells, along with aqueous control solutions. Caffeine and naproxen fluxes were determined over 8 h. Solute solubility in the formulations and in the stratum corneum (SC), as well as the uptake of product components into the SC were measured. The nanoemulsions significantly enhanced the skin penetration of caffeine and naproxen, compared to aqueous control solutions. Caffeine maximum flux enhancement was associated with a synergistic increase in both caffeine SC solubility and skin diffusivity, whereas a formulation-increased solubility in the SC was the dominant determinant for increased naproxen fluxes. Enhancements in SC solubility were related to the uptake of the formulation excipients containing the active compounds into the SC. Enhanced skin penetration in these systems is largely driven by uptake of formulation excipients containing the active compounds into the SC with impacts on SC solubility and diffusivity.
我们研究了在含有皮肤渗透促进剂的纳米乳剂中应用的亲水性药物咖啡因和亲脂性药物萘普生的皮肤渗透增强程度。将含有皮肤渗透促进剂油酸或桉叶油作为油相以及咖啡因(3%)或萘普生(2%)的充分表征的水包油纳米乳剂的无限剂量,与水性对照溶液一起应用于Franz扩散池中人类表皮膜。在8小时内测定咖啡因和萘普生的通量。测量了溶质在制剂和角质层(SC)中的溶解度,以及产品成分进入SC的摄取量。与水性对照溶液相比,纳米乳剂显著增强了咖啡因和萘普生的皮肤渗透。咖啡因最大通量增强与咖啡因SC溶解度和皮肤扩散率的协同增加有关,而制剂在SC中溶解度的增加是萘普生通量增加的主要决定因素。SC溶解度的增强与含有活性化合物的制剂辅料进入SC有关。这些系统中皮肤渗透的增强主要是由含有活性化合物的制剂辅料进入SC驱动的,对SC溶解度和扩散率有影响。
Skin Pharmacol Physiol. 2019-3-25
Colloids Surf B Biointerfaces. 2009-9-13
Int J Pharm. 1999-5-10
Drug Deliv Transl Res. 2025-2-21
AAPS PharmSciTech. 2025-1-10
Antioxidants (Basel). 2024-7-28
Pharmaceutics. 2023-9-26